In the pursuit of market outperformance, investors navigate the landscape of stock selection. The right picks can play a pivotal role in enhancing your wealth.
The price of Nuvation Bio Inc (NYSE: NUVB) closed at $2.17 in the last session, down -5.65% from day before closing price of $2.30. In other words, the price has decreased by -$5.65 from its previous closing price. On the day, 5.65 million shares were traded. NUVB stock price reached its highest trading level at $2.3 during the session, while it also had its lowest trading level at $2.1.
Ratios:
We take a closer look at NUVB’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 9.01 and its Current Ratio is at 9.01. In the meantime, Its Debt-to-Equity ratio is 0.03 whereas as Long-Term Debt/Eq ratio is at 0.01.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Citizens JMP on April 23, 2025, initiated with a Mkt Outperform rating and assigned the stock a target price of $6.
On March 27, 2024, Jefferies Upgraded its rating to Buy which previously was Hold and also upped its target price recommendation from $1.40 to $10.
BTIG Research Upgraded its Neutral to Buy on March 26, 2024, while the target price for the stock was maintained at $5.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on May 02 ’25 when Liu Dongfang sold 20,000 shares for $2.50 per share. The transaction valued at 50,024 led to the insider holds 12,000 shares of the business.
DONGFANG LIU bought 20,000 shares of NUVB for $45,400 on May 02 ’25. On Apr 07 ’25, another insider, Hung David, who serves as the PRESIDENT AND CEO of the company, bought 300,000 shares for $1.62 each. As a result, the insider paid 487,500 and bolstered with 58,781,054 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, NUVB now has a Market Capitalization of 738370752 and an Enterprise Value of 288107648. For the stock, the TTM Price-to-Sale (P/S) ratio is 67.37 while its Price-to-Book (P/B) ratio in mrq is 1.76. Its current Enterprise Value per Revenue stands at 26.294 whereas that against EBITDA is -1.402.
Stock Price History:
The Beta on a monthly basis for NUVB is 1.40, which has changed by -0.3384146 over the last 52 weeks, in comparison to a change of 0.11936104 over the same period for the S&P500. Over the past 52 weeks, NUVB has reached a high of $3.97, while it has fallen to a 52-week low of $1.54. The 50-Day Moving Average of the stock is 6.78%, while the 200-Day Moving Average is calculated to be -11.66%.
Shares Statistics:
According to the various share statistics, NUVB traded on average about 3.07M shares per day over the past 3-months and 3310980 shares per day over the past 10 days. A total of 338.84M shares are outstanding, with a floating share count of 226.75M. Insiders hold about 33.36% of the company’s shares, while institutions hold 48.58% stake in the company. Shares short for NUVB as of 1745971200 were 33098485 with a Short Ratio of 10.79, compared to 1743379200 on 32099291. Therefore, it implies a Short% of Shares Outstanding of 33098485 and a Short% of Float of 15.93.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
